UNAIDS 2018 / Guidance
Guidance for policy-makers, and people living with, at risk of or affected by HIV
In disaster preparedness, the participation of women, children, older people, persons with disabilities (PWDs), and other minority groups and sectors is important because they are the most vulnerable against disasters. Inclusive disaster preparedness provides technical and logical frameworks that as...similate the most vulnerable sectors in a community and enhances their capacity against future disasters.
more
PLOS ONE | https://doi.org/10.1371/journal.pone.0193145 February 22, 2018 1 / 13
Web annex 2: Carbetocin versus placebo or no treatment
Evidence to decision framework
SADF POLICY BRIEF
31 October 2018 Issue n° 8
ISSN: 2406-5625
2018
9th Edition
Offering information on HIV/AIDS treatment, prevention, and research
Tackling Tuberculosis in Under-Served Populations: A Resource for TB Control Boards and their partners
Practical Guidance for collaborative interventions
SDG target 3.3: by 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, waterborne diseases and other communicable diseases.
The WHO Toolkit for the care and support of people affected by complications associated with Zika virus has been developed to serve as a model guide, with the goal of enhancing country preparedness for Zika virus outbreaks. The toolkit is intended to provide a systems approach involving public heal...th planners and managers so that the necessary infrastructure and resources can be identified and incorporated as needed, as well as technical and practical guidance for health care professionals and community workers.
The toolkit includes three manuals to provide countries with tools to effectively recognize people affected by Zika virus and deliver comprehensive care and support:
Manual for public health planners and managers
Manual for health care professionals
Manual for community workers
more
Replacement of Annex 2 of WHO Technical Report Series, No. 964... morbidity. These preparations are included in the WHO List of Essential Medicines and should be part of any primary health care package where snakebites occur. Currently, there is an urgent need to ensure availability of safe, effective and affordable antivenoms, particularly to those in developing countries and to improve the regulatory control over the manufacture, import and sale of antivenoms.>
more
Dialogues Clin Neurosci. 2017 Jun; 19(2): 93–107.